In contrast to the UK AATD national registry, the AAT Genetic Modifiers Study has shown that SNPs in the genes IREB2, LOC123688, and CHRNA3 are associated with specific lung function phenotypes in AATD PI*ZZ subjects. This evidence concerns the gene CHRNA3 and alpha 1-antitrypsin deficiency.